Home/BioInvent International/Björn Frendéus
BF

Björn Frendéus

Founder & Chief Scientific Officer

BioInvent International

Therapeutic Areas

BioInvent International Pipeline

DrugIndicationPhase
BI-1206Non-Hodgkin's LymphomaPhase 1/2
BI-1808Advanced Solid TumorsPhase 1/2
BI-1607Advanced Solid TumorsPhase 1/2
BT-001Solid TumorsPhase 1/2